Fundz

Watching Scribe Therapeutics Inc.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Bylaws AmendmentItem 5.03 · 8-KLOW RiskPositive

Scribe Therapeutics Inc.

Filed: Jul 27, 2026CIK: 000182157847Health Care
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Scribe Therapeutics Inc. filed amended and restated Certificate of Incorporation and Bylaws with Delaware on July 27, 2026, effective upon closing of its IPO. This routine corporate governance update reflects the company's transition to public company status and compliance with securities regulations.

Key Takeaways

Company completed its initial public offering on July 27, 2026, with final prospectus dated July 23, 2026

Amended and Restated Certificate of Incorporation and Bylaws were approved by board and stockholders and became effective at IPO closing

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJul 27, 2026
Item5.03
CategoryBylaws Amendment
CIK000182157847
Accession #0001437749-26-000005
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
ipo spac

What This Means

Corporate governance documents have been amended. Review for changes that affect shareholder rights.
View Full Filing on SEC.govBrowse More Filings

Scribe Therapeutics Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.